Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: This is the largest study in North America investigating olfactory outcomes after pituitary surgery to date.

Objective: Characterize factors associated with subjective olfactory dysfunction (OD) and worsened sinonasal quality-of-life (QOL) after endoscopic TSA.

Methods: Patients undergoing primary TSA for secreting and non-secreting pituitary adenomas between 2017 and 2021 with pre- and post-operative SNOT-22 scores were included. Subjective OD was determined by the smell/taste dysfunction question on the SNOT-22 (smell-SNOT).

Results: 159 patients with pre- and post-operative SNOT-22 scores were included. Average total SNOT-22 scores worsened from pre-operative (16.91 ± 16.91) to POM1 (25.15 ± 20.83,  < .001), with no difference from pre-operative (16.40 ± 15.88) to POM6 (16.27 ± 17.92,  = .936) or pre-operative (13.63 ± 13.54) to POM12 (12.60 ± 16.45,  = .651). Average smell-SNOT scores worsened from pre-operative (0.40 ± 1.27) to POM1 (2.09 ± 2.01,  < .001), and pre-operative (0.46 ± 1.29) to POM6 (1.13 ± 2.45,  = .002), with no difference from pre-operative (0.40 ± 1.07) to POM12 (0.71 ± 1.32,  = .100). Female gender had a 0.9-point (95% CI 0.1 to 1.6)  = .021, increase in smell-SNOT at POM1, resolving by POM6 (0.1 [-0.9 to 1.1],  = .800) and POM12 (0.0 [-1.0 to 0.9],  = .942). Septoplasty with tunnel approach had a 1.1 [0.2 to 2.0] out of 5-point ( = .023) increase in smell-SNOT at POM1, resolving by POM6 (0.2 [-1.1 to 1.6],  = .764) and POM12 (0.4 [-0.9 to 1.6],  = .567). Female gender had a 9.5 (4.0 to 15.1)-point ( = .001) increase in SNOT-22 scores at POM1, resolving by POM6 (3.4 [-3.0 to 9.8],  = .292) and POM12 (6.4 [-5.4 to 18.2],  = .276). Intra-operative CSF leak had an 8.6 [2.1 to 15.1]-point ( = .009) increase in SNOT-22 scores at POM1, resolving by POM6 (5.4 [-1.7 to 12.5],  = .135), and POM12 (1.1 [-12.9 to 15.1],  = .873).

Conclusion: Changes in subjective olfaction and sinonasal QOL after TSA may be associated with gender, operative approach, and intra-operative CSF leak, resolving 6-12 months post-operatively.

Download full-text PDF

Source
http://dx.doi.org/10.1177/19458924241243123DOI Listing

Publication Analysis

Top Keywords

snot-22 scores
12
subjective olfactory
8
olfactory dysfunction
8
sinonasal quality-of-life
8
pituitary surgery
8
pre- post-operative
8
post-operative snot-22
8
scores included
8
predictors subjective
4
dysfunction sinonasal
4

Similar Publications

Background: This study aimed to evaluate the presence of Serpentine Signs on computed tomography (CT) images and its impact on the clinical symptoms in patients with empty nose syndrome (ENS).

Methods: A retrospective study analysed patients with ENS enrolled in previous studies. The clinical characteristics and results of ENS-specific questionnaire evaluations were reviewed.

View Article and Find Full Text PDF

Introduction: Chronic rhinosinusitis with nasal polyp (CRSwNP) is a predominant type 2 inflammatory disease, affecting the sense of smell and quality of life. Loss of smell compromises physical and emotional health, creating negative impacts and its treatment in CRSwNP is challenging.

Aim: To present the outcomes of dupilumab in olfactory function, Nasal Polyp Score (NPS) and quality of life in Brazilian patients with severe CRSwNP.

View Article and Find Full Text PDF

Background: Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a heterogeneous disorder characterized by diverse inflammatory signatures and endotypes.

Objective: To develop a histology-based deep learning network for predicting inflammatory gene signatures and spatial patterns in CRSwNP.

Methods: We developed HE2Signature, a deep learning model, using 70 H&E-stained whole-slide images (WSIs) of nasal polyps paired with corresponding endotypic signature gene expression profiles derived from transcriptomic data.

View Article and Find Full Text PDF

To explore the effect, postoperative mucosal pathological changes and molecular biological changes of reboot operation for type 2 inflammation chronic rhinosinusitis with nasal polyps(CRSwNP) patients, and to provide theoretical basis for the clinical application of this kind of operation. We collected 29 patients who were diagnosed with CRSwNP with type 2 inflammatino response and underwent Reboot surgery from June 2022 to August 2023, and 27 patients who were diagnosed with deviated septum and underwent simple submucosal resection of the septum as the control group. We conducted nasal symptom scoring, endoscopic sinusitis scoring, and CT scanning of the sinuses before and after surgery, as well as HE staining, immunohistochemical staining, and detection of inflammatory factors using Elisa kits at the time of surgery, 1, 3, and 6 months postoperatively.

View Article and Find Full Text PDF

Background: A paucity of evidence regarding use of endoscopic sinus surgery and antibiotics in managing chronic rhinosinusitis has contributed to a five-times variation in endoscopic sinus surgery rates, as well as variation in the use of antibiotics. The main aim of the present trial was to compare the clinical effectiveness of endoscopic sinus surgery or 3 months of clarithromycin treatment alongside intranasal medication in adults with chronic rhinosinusitis with or without nasal polyps.

Methods: In this pragmatic, three-arm, randomised, placebo-controlled phase 4 trial, participants were recruited from 20 secondary and tertiary care sites in the UK.

View Article and Find Full Text PDF